Geron Seen as Scientifically and Financially Risky
Doctors, scientists, and now also institutional investors lack confidence in Geron’s highly publicized upcoming clinical trial with human embryonic stem cells.
Doctors, scientists, and now also institutional investors lack confidence in Geron’s highly publicized upcoming clinical trial with human embryonic stem cells.
Obama also formally rescinded President Bush’s Executive Order that advocated research into non-embryonic sources of stem cells, such as adult stem cells and iPS cells.
Adult stem cell therapy continues to yield significant improvement in patients with a variety of heart problems.
Amid great publicity, fanfare, and confusion, President Barack Obama reverses some, but not all, of the laws that previously governed stem cell research.
Dr. Bernardine Healy has written an article in U.S. News and World Report entitled Why Embryonic Stem Cells Are Obsolete.
JCR Pharmaceuticals has begun clinical trials for the treatment of graft-versus-host disease with mesenchymal stem cells derived from bone marrow.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.